Abstract:Background: Rectal cancer is one of the most prevalent tumor types. Understanding the metabolic profile of rectal cancer is important for developing therapeutic approaches and molecular diagnosis. Methods: Here, we report a metabonomics profiling of tissue samples on a large cohort of human rectal cancer subjects (n = 127) and normal controls (n = 43) using 1H nuclear magnetic resonance (1H NMR) based metabonomics assay, which is a highly sensitive and non-destructive method for the biomarker identification in biological systems. Principal component analysis (PCA), partial least squares discriminant analysis (PLS-DA) and orthogonal projection to latent structure with discriminant analysis (OPLS-DA) were applied to analyze the 1H-NMR profiling data to identify the distinguishing metabolites of rectal cancer. Results: Excellent separation was obtained and distinguishing metabolites were observed among the different stages of rectal cancer tissues (stage I = 35; stage II = 37; stage III = 37 and stage IV = 18) and normal controls. A total of 38 differential metabolites were identified, 16 of which were closely correlated with the stage of rectal cancer. The up-regulation of 10 metabolites, including lactate, threonine, acetate, glutathione, uracil, succinate, serine, formate, lysine and tyrosine, were detected in the cancer tissues. On the other hand, 6 metabolites, including myo-inositol, taurine, phosphocreatine, creatine, betaine and dimethylglycine were decreased in cancer tissues. These modified metabolites revealed disturbance of energy, amino acids, ketone body and choline metabolism, which may be correlated with the progression of human rectal cancer. Conclusion: Our findings firstly identify the distinguishing metabolites in different stages of rectal cancer tissues, indicating possibility of the attribution of metabolites disturbance to the progression of rectal cancer. The altered metabolites may be as potential biomarkers, which would provide a promising molecular diagnostic approach for clinical diagnosis of human rectal cancer. The role and underlying mechanism of metabolites in rectal cancer progression are worth being further investigated.

Metabonomic Characteristics and Biomarker Research of Human Lung Cancer Tissues by HR1H NMR Spectroscopy.

Metabonomic Characteristics of Human Lung Cancer Using High Resolution 1H NMR Spectroscopy and Multivariate Data Analysis

Optimization of Volatile Markers of Lung Cancer to Exclude Interferences of Non-Malignant Disease

Staging Research of Human Lung Cancer Tissues by High‐resolution Magic Angle Spinning Proton Nuclear Magnetic Resonance Spectroscopy (HRMAS 1H NMR) and Multivariate Data Analysis

Lung cancer diagnosis method by detecting metabolic gases of lung cells

Metabolic Profiling of Human Colorectal Cancer Using High Resolution 1H Nuclear Magnetic Resonance Spectroscopy

¹H NMR-based metabolic profiling of human rectal cancer tissue

Metabonomic Studies of Human Hepatocellular Carcinoma Using High-Resolution Magic-Angle Spinning 1H NMR Spectroscopy in Conjunction with Multivariate Data Analysis.

Study of Metabonomic Profiles of Human Esophageal Carcinoma by Use of High-Resolution Magic-Angle Spinning 1H NMR Spectroscopy and Multivariate Data Analysis

High-resolution metabolomic biomarkers for lung cancer diagnosis and prognosis

Non-Targeted and Targeted Metabolomics Approaches to Diagnosing Lung Cancer and Predicting Patient Prognosis

Metabolic alterations caused by smoking: the use of 1H-NMR in blood plasma analysis to unravel underlying mechanisms of lung cancers leading risk factor

1H-NMR-based metabolomics of tumor tissue for the metabolic characterization of rat hepatocellular carcinoma formation and metastasis

Tissue Metabonomic Phenotyping for Diagnosis and Prognosis of Human Colorectal Cancer

High-Resolution Magic Angle Spinning Nuclear Magnetic Resonance Spectroscopy of Paired Clinical Liver Tissue Samples from Hepatocellular Cancer and Surrounding Region

Diagnosis and Correlation Analysis of Lung Cancer Based on Multi-Parameter Regression of Respiratory Volatile Organic Compounds

A proton nuclear magnetic resonance metabonomics approach for biomarker discovery in nonalcoholic fatty liver disease.

[Study on the Malignant and Normal Rectum Tissues Using 1H NMR Spectroscopy].

Understanding metabolomic characteristics of pancreatic ductal adenocarcinoma by HR-MAS NMR detection of pancreatic tissues

Metabolomic Differentiation of Benign Vs Malignant Pulmonary Nodules with High Specificity Via High-Resolution Mass Spectrometry Analysis of Patient Sera.

Integrated ionization approach for RRLC-MS/MS-based metabonomics: finding potential biomarkers for lung cancer.